Effect of Medication Co-payment Vouchers on P2Y(12) Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial

IMPORTANCE: Despite guideline recommendations, many patients discontinue P2Y(12) inhibitor therapy earlier than the recommended 1 year after myocardial infarction (MI), and higher-potency P2Y(12) inhibitors are underutilized. Cost is frequently cited as an explanation for both of these observations....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JAMA
Prif Awduron: Wang, Tracy Y., Kaltenbach, Lisa A., Cannon, Christopher P., Fonarow, Gregg C., Choudhry, Niteesh K., Henry, Timothy D., Cohen, David J., Bhandary, Durgesh, Khan, Naeem D., Anstrom, Kevin J., Peterson, Eric D.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Medical Association 2019
Pynciau:
Original Investigation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583585/
https://ncbi.nlm.nih.gov/pubmed/30620370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.19791
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg